Guided Therapeutics Statistics
Total Valuation
GTHP has a market cap or net worth of 26.07 million. The enterprise value is 29.56 million.
| Market Cap | 26.07M |
| Enterprise Value | 29.56M |
Important Dates
The next estimated earnings date is Friday, August 21, 2026.
| Earnings Date | Aug 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
GTHP has 96.54 million shares outstanding. The number of shares has increased by 32.38% in one year.
| Current Share Class | 96.54M |
| Shares Outstanding | 96.54M |
| Shares Change (YoY) | +32.38% |
| Shares Change (QoQ) | +8.67% |
| Owned by Insiders (%) | 42.68% |
| Owned by Institutions (%) | 4.40% |
| Float | 40.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 40.10 |
| PB Ratio | -4.52 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 45.47 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.09
| Current Ratio | 0.09 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.85 |
| Interest Coverage | -3.29 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -115.63% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 39.71% |
| Weighted Average Cost of Capital (WACC) | 9.09% |
| Revenue Per Employee | 216,667 |
| Profits Per Employee | -1.21M |
| Employee Count | 3 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 0.29 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +18.94% in the last 52 weeks. The beta is 0.72, so GTHP's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | +18.94% |
| 50-Day Moving Average | 0.25 |
| 200-Day Moving Average | 0.28 |
| Relative Strength Index (RSI) | 51.28 |
| Average Volume (20 Days) | 10,593 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.14 |
Income Statement
In the last 12 months, GTHP had revenue of 650,000 and -3.64 million in losses. Loss per share was -0.04.
| Revenue | 650,000 |
| Gross Profit | 492,000 |
| Operating Income | -1.98M |
| Pretax Income | -3.07M |
| Net Income | -3.64M |
| EBITDA | -1.97M |
| EBIT | -1.98M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 12,000 in cash and 2.79 million in debt, with a net cash position of -2.77 million or -0.03 per share.
| Cash & Cash Equivalents | 12,000 |
| Total Debt | 2.79M |
| Net Cash | -2.77M |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | -5.76M |
| Book Value Per Share | -0.07 |
| Working Capital | -5.64M |
Cash Flow
In the last 12 months, operating cash flow was -1.50 million and capital expenditures -2,000, giving a free cash flow of -1.51 million.
| Operating Cash Flow | -1.50M |
| Capital Expenditures | -2,000 |
| Depreciation & Amortization | 9,000 |
| Net Borrowing | 21,000 |
| Free Cash Flow | -1.51M |
| FCF Per Share | -0.02 |
Margins
| Gross Margin | 75.69% |
| Operating Margin | -303.85% |
| Pretax Margin | -471.54% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GTHP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -32.38% |
| Shareholder Yield | -32.38% |
| Earnings Yield | -13.98% |
| FCF Yield | -5.78% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 29, 2019. It was a reverse split with a ratio of 0.00125.
| Last Split Date | Mar 29, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.00125 |
Scores
GTHP has an Altman Z-Score of -194.41 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -194.41 |
| Piotroski F-Score | 3 |